Overview
- The Paris prosecutor formally requested a trial on April 7, 2025, against Senator Joël Guerriau for allegedly drugging MP Sandrine Josso with MDMA to facilitate sexual assault.
- Toxicological analysis revealed 388 ng/ml of MDMA in Josso's blood, significantly exceeding recreational levels, with no prior drug use detected in the months preceding the incident.
- Investigators uncovered inconsistent statements from Guerriau and online searches related to drugs and sexual violence, suggesting awareness and intent.
- Guerriau has been under judicial control since his indictment and was suspended from his political party and parliamentary group, though he has refused to resign.
- The case highlights broader concerns about chemical submission and abuse of power within political institutions, sparking calls for accountability at the highest levels.